Summary:
Summary Statement of Deficiencies D0000 An unannounced follow up survey was conducted 03/26/2018 to 03/27/2018. The laboratory resolved the condition level deficiencies cited previously, with only standard level deficiencies still remaining. ******************** 33867 An unannounced investigation of complaint TX00263879 conducted on site. An entrance conference was held with the Technical Supervisor on 07/10/17 to explain the purpose and process of the survey. Based on the onsite survey conducted on 07/10/17 through 07/14/17, this facility was found NOT to be in compliance with the CLIA regulations found at 42 CFR 493.1240 Preanalytical Systems 493.1250 Analytic Systems 493.1441 Laboratory Director High Complexity 493.1447 Technical Supervisor 493.1487 Testing Personnel An exit conference was held with Technical Supervisor #1, #2, Regulatory and Compliance Coordinator, Vice President Operations, Technical Supervisor for Pharmacogenetics, Chief Compliance Officer, CFO, CEO, President, VP of Human Resources, Laboratory Director and Supervisor of Toxicology on 07/14/17. Survey findings were discussed. Complaint TX00263879 was substantiated 2567 report to be sent to Regional CMS office. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --